Gene Query: RAB3D

Dataset Description Geneva Score
Silencing p300 in MCF7 cells to study expression and alternative splicing 39.28
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 34.38
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 31.55
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 30.5
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 30.11
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 28.71
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 28.43
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 27.82
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 27.82
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 27.17
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 26.67
Gene expression changes caused by KRAS in MCF-10A 26.32
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 25.74
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 24.57
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 23.22
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 21.4
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 21.01
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 21.01
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 20.87
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 20.46
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 20.46
Role of CD133 molecule in WNT response and renal repair 20.3
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 20.06
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 19.92
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 19.82
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 19.69
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 19.16
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 18.18
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 18.18
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 18.13
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 18.04
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  18.03
Control of prostate tumour growth by the long non-coding RNA GHSROS 18.01
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 17.99
Genome wide expression change in LCC2 and MCF-7 cells 17.97
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 17.95
RNA sequencing of BT142 and TS603 cell lines 17.51
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 17.51
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 17.5
Expression by CD133+ cells isolated from the adult human exocrine pancreas 17.32
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 17.22
Peptidomimetic blockade of MYB in acute myeloid leukemia 17.22
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 16.89
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 16.71
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 16.2
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 16.2
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 15.97
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 15.84
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 15.76
Patient-derived luminal breast cancer xenografts with progestins 15.76
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 15.7
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 15.62
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 15.39
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 15.39
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 15.23
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 15.23
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 15.16
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 15.11
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 15.1
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 15.1
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 14.93
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 14.93
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 14.72
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 14.72
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 14.39
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 14.38
Targeting MTHFD2 in Acute Myeloid Leukemia 14.3
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 14.21
CircRNAome diversity in human mature B-cells, T-cells and monocytes 13.98
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 13.8
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 13.77
Transcriptomes of human monocytes after ex vivo exposure to uric acid 13.71
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 13.62
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 13.62
Dynamic 3D chromosomal landscapes in acute leukemia 13.49
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 13.49
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 13.4
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 13.11
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 13.08
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 12.9
Intron retention induced by microsatellite expansions as a disease biomarker. 12.67
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 12.58
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 12.56
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 12.56
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 12.56
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 12.55
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 12.51
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 12.48
Role for citron kinase in prostate cancer growth 12.4
Tpl-2 and MEK small molecule inhibitors 12.4
Tpl-2 small molecule project 12.4
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 12.32
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 12.05
Dtx3L and Androgen Signaling in Prostate Cancer 12.03
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 11.88
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 11.86
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 11.82
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 11.66
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 11.62
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 11.58
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 11.58
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 11.48
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 11.34
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 11.34
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 11.31
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 11.3
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 11.3
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 11.3
CSL RNA-Seq on HKC and SCC cell lines 11.29
CSL 11.29
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 11.25
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.22
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.22
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 11.1
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 11.06
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 10.98
Epigenome regulation during epidermal lineage commitment [RNA-seq] 10.88
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 10.86
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 10.86
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 10.86
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 10.86
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 10.84
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 10.81
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 10.79
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 10.79
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 10.79
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 10.79
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 10.77
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 10.71
Human neutrophil genome during PMA- and E. coli encounter-induced activation 10.71
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 10.71
G-quadruplex structures mark human regulatory chromatin 10.62
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 10.6
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 10.6
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 10.59
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 10.57
RNA-seq differential expression studies: more sequence, or more replication? 10.44
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 10.43
Lipid degradation promotes prostate cancer cell survival 10.34
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 10.3
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 10.26
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 10.24
SUV420H2 knockdown in PANC-1 10.09
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 10.0
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 9.89
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 9.89
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 9.89
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 9.89
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.81
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.68
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 9.65
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 9.65
SLIGRL-induced gene expression changes in NHEK cells 9.65
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 9.65
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.62
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 9.6
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 9.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 9.59
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 9.56
NR2F2 study 9.54
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 9.54
The role of FAM46C in myeloma cells [sequencing] 9.5
The role of FAM46C in myeloma cells 9.5
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 9.47
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 9.47
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 9.45
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 9.43
Transcriptional profile in human S. haematobium infection 9.27
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 9.24
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 9.15
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 9.14
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 9.13
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.1
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 9.09
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 8.92
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 8.92
Overexpression of NFIB and YBX1 in MCF-7 cells 8.92
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 8.89
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 8.89
Silencing SPIB in attached and floating state of H1703 lung cancer cells 8.84
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 8.84
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 8.79
Genome-wide Analysis of Chromatin Interactions in Human Cells 8.74
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 8.63
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 8.61
Regulation of Lipids is Central to Replicative Senescence 8.57
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 8.4
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 8.34
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 8.31
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 8.29
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 8.23
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.22
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 8.21
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 8.21
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 8.12
Gene expression profile in breast cancer cell lines using RNA sequencing 8.08
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 8.06
Overexpression and knockdown experiment for circCSNK1G3 8.05
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 7.98
RNA-Seq in neutrophils from Antiphospholipid Syndrome 7.97
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 7.96
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 7.96
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 7.92
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 7.85
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 7.81
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 7.81
RNA-seq of MCF10A cells and CAF 7.8
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 7.79
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 7.76
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 7.76
BASP1 modifies the Tamoxifen response 7.74
IRF2 is a master regulator of human keratinocyte stem cell fate 7.71
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 7.71
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 7.69
Triple vectors expand AAV transfer capacity in the retina 7.68
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 7.67
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 7.58
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.52
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 7.52
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 7.51
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.47
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 7.46
Dysregulated immune system networks in war veterans with PTSD 7.44
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 7.4
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 7.37
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 7.31
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 7.31
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.31
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.26
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 7.22
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 7.22
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 7.19
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 7.14
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 7.12
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.12
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 7.12
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 7.12
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 7.11
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.07
Differential Gene Expression between MCF10A and MCF7 cells 7.01
Statins modulate endothelial transcriptional profile by inhibiting EZH2 6.98
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 6.89
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.88
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 6.88
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.88
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 6.85
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 6.78
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.75
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 6.75
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 6.75
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.75
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 6.72
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 6.71
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 6.71
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.68
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 6.64
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.6
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  6.59
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 6.57
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 6.57
RNA-seq analysis of breast cancer 6.56
RNA-seq analysis and shRNA screen of breast cancer 6.56
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 6.56
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 6.56
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 6.53
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 6.53
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 6.51
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 6.49
RNA-seq of YB5 cells treated with Proscillaridin A 6.45
WRN knockout effects upon gene expression in SW48 and OVK18 6.45
snRNAs as regulators of alternative splicing 6.43
RNA-seq of naive and primed ES cells 6.43
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 6.42
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.33
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 6.33
Integrin signaling regulates YAP/TAZ to control skin homeostasis 6.29
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.26
RNA-seq of shEZH2 cells 6.19
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 6.18
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.16
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 6.13
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 6.13
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 6.02
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 6.0
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 5.93
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 5.9
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 5.9
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 5.9
HNF1 regulates critical functions of the human epididymis epithelium. 5.86
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 5.86
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 5.85
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 5.82
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 5.76
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 5.75
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 5.75
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 5.74
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 5.73
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 5.73
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.64
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 5.63
Interaction between mitoNEET and NAF-1 in cancer cells 5.62
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 5.6
Rorc disruption in human FG pancreatic cancer cells 5.56
Transcription control by the ENL YEATS domain in acute leukemia 5.5
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 5.5
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 5.44
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.44
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 5.43
The pioneer factor CEBPA modulates vitamin D signaling 5.43
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 5.41
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.35
Expression profiling of MCF-7 cells with treatment of TCDD 5.32
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 5.32
RNAseq of IL-36 stimulated primary human keratinocytes 5.28
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 5.25
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 5.21
Identification of HOXB13 target genes responsive to BET inhibitors 5.2
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 5.18
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 5.18
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 5.17
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 5.15
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 5.15
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 5.15
A prostate cancer chromatin interaction map 5.13
RNA sequencing of human mammary epithelial cells 5.09
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 5.07
Epigenome regulation during epidermal lineage commitment 5.03
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 5.02
Transcriptome analysis of kidney organoids 5.0
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 4.93
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 4.83
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 4.72
Identification of long noncoding RNAs regulated by p53 4.7
MCF-7 as a model for functional analysis of breast cancer risk variants 4.67
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.61
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.53
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.48
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 4.46
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 4.39
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.38
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 4.32
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.25
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.25
Identification of long noncoding RNAs in T-ALL cell lines 4.24
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 4.23
mRNA-sequencing of breast cancer subtypes and normal tissue 4.18
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 4.08
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.08
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.08
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.04
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 4.03
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 4.01
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 4.01
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.0
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 3.99
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.96
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 3.88
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.87
p63 controls the enhancer landscape during keratinocyte differentiation 3.8
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.77
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.76
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.75
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 3.75
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 3.73
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.61
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.59
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.56
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.56
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 3.54
Gene expression alterations of pancreatic intraepithlial neoplasia 3.47
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.43
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.34
A map of gene expression in neutrophil-like cell lines 3.31
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 3.25
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.24
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.21
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.15
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.14
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.07
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 3.0
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 3.0
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 2.97
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 2.97
Gene expression patterns define the hepatocyte-like cells derived by different strategies 2.97
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 2.97
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.97
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 2.96
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.92
Fusion discovery in breast cancer cell line 2.85
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 2.81
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.81
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.76
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 2.69
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.67
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.63
Transcriptome analysis of peripheral blood monocytes 2.63
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.57
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.56
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.56
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 2.55
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 2.54
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.47
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.44
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.43
Next generation sequencing of small RNAs isolated from exosomes in human semen 2.38
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.36
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.21
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 2.21
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.2
RNA-seq of cancer cell lines treated with T-025 2.17
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.14
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.13
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.09
RNA-Seq and expression data from human adipose tissue 2.09
Investigate A2M treatment on human prostate cancer and mouse liver 2.02
Investigate A2M treatment on human prostate cancer xenograft in mice 2.02
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.99
Identification of global XBP1s target gene expression in human prostate cancer cells 1.97
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 1.97
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 1.94
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 1.93
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.86
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 1.86
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 1.86
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.84
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.82
Downregulation of LATS kinases alters p53 to promote cell migration 1.82
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.8
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.78
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 1.78
quanTIseq: quantifying immune contexture of human tumors 1.78
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 1.75
RNAseq of Breast cancer PDX samples 1.74
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 1.69
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 1.69
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.66
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 1.63
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 1.61
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 1.54
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 1.52
Human islets of varying quality: the good, the (not so) bad and the ugly 1.51
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 1.37
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.36
Interphase condensins regulate ligand-depedent enhancer activation 1.36
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 1.32
Gene expression analysis of breast cancer cell-lines 1.3
Gene expression and genome-wide location analysis of breast cancer cell-lines 1.3
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.26
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.25
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 1.24
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.22
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.19
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.17
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.11
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.1
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.1
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.09
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 1.09
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 1.09
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 1.03
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.02
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.98
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 0.92
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.87
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.87
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.84
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.82
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.79
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.77
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.76
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.75
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.73
The gene expression profiles of gallbladder cancer 0.73
Common inflammatory pathways between NEC and Crohn's disease 0.71
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.67
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.67
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.67
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.67
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.67
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.67
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.64
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.6
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.55
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.5
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.49
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.38
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.34
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.34
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.29
Expression analysis of the TAF1 syndrome 0.17
RNA-seq of IL-4 stimulated human keratinocytes 0.15
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 0.14
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 0.11
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 0.11
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.1
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.02
A Unique Epigenomic Landscape Defines Human Erythropoiesis 0.02
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 0.02
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.02
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation